Welcome to Elusys Therapeutics, Inc. Elusys is a private, commercial-stage biopharmaceutical company that has achieved US and international licensure in Canada, the UK, and the EU for its lead antibody therapeutic, a medical countermeasure to treat patients following anthrax exposure after a natural or intentional terrorist incident. OUR PRODUCTS Learn more OUR PARTNERS About Us PRESS RELEASES December 2, […]
Location: United States, New Jersey, Tinton Falls
Member count: 11-50
Founded date: 1998
Investors 2
Date | Name | Website |
14.05.2021 | EW Healthc... | ewhealthca... |
- | Seed-One C... | seedone.co... |
Mentions in press and media 1
Date | Title | Description | Category | Author | Source |
26.09.2007 | Life scien... | Featured companies: Ablynx, Ca... | - | - | venturebea... |